ResearcherKindai UniversityNo recent work listed
Yosuke Togashi
Matched on ORCID iD 0000-0001-9910-0164; OpenAlex author ID A5033862426. Sources: OpenAlex.
Their work
- Papers
- 4 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 20
2014: 1 paper · 2015: 2 papers · 2016: none · 2017: 1 paper
Papers 4
- Clinical significance of Akt2 in advanced pancreatic cancer treated with erlotinib. First author DOI 10.3892/ijo.2017.3961↗
- Activin signal promotes cancer progression and is involved in cachexia in a subset of pancreatic cancer. Co-author DOI 10.1016/j.canlet.2014.10.037↗
- Randomized phase II/III clinical trial of elpamotide for patients with advanced pancreatic cancer: PEGASUS-PC Study. Co-author DOI 10.1111/cas.12674↗
- Homozygous deletion of the activin A receptor, type IB gene is associated with an aggressive cancer phenotype in pancreatic cancer. Co-author DOI 10.1186/1476-4598-13-126↗
Closest collaborators
The 20 strongest of 20 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Kazuto Nishio · 4 shared papers, 2014–2017 · strength 0.18
- Paper Clinical significance of Akt2 in advanced pancreatic cancer treated with erlotinib. DOI 10.3892/ijo.2017.3961↗
- Paper Activin signal promotes cancer progression and is involved in cachexia in a subset of pancreatic cancer. DOI 10.1016/j.canlet.2014.10.037↗
- Paper Randomized phase II/III clinical trial of elpamotide for patients with advanced pancreatic cancer: PEGASUS-PC Study. DOI 10.1111/cas.12674↗
- Masatoshi Kudo · 3 shared papers, 2014–2017 · strength 0.14
- Paper Clinical significance of Akt2 in advanced pancreatic cancer treated with erlotinib. DOI 10.3892/ijo.2017.3961↗
- Paper Activin signal promotes cancer progression and is involved in cachexia in a subset of pancreatic cancer. DOI 10.1016/j.canlet.2014.10.037↗
- Paper Homozygous deletion of the activin A receptor, type IB gene is associated with an aggressive cancer phenotype in pancre… DOI 10.1186/1476-4598-13-126↗
- Masayuki Kitano · 3 shared papers, 2014–2017 · strength 0.14
- Paper Clinical significance of Akt2 in advanced pancreatic cancer treated with erlotinib. DOI 10.3892/ijo.2017.3961↗
- Paper Activin signal promotes cancer progression and is involved in cachexia in a subset of pancreatic cancer. DOI 10.1016/j.canlet.2014.10.037↗
- Paper Homozygous deletion of the activin A receptor, type IB gene is associated with an aggressive cancer phenotype in pancre… DOI 10.1186/1476-4598-13-126↗
- Hiroki Sakamoto · 2 shared papers, 2014–2015 · strength 0.08
- Paper Activin signal promotes cancer progression and is involved in cachexia in a subset of pancreatic cancer. DOI 10.1016/j.canlet.2014.10.037↗
- Paper Homozygous deletion of the activin A receptor, type IB gene is associated with an aggressive cancer phenotype in pancre… DOI 10.1186/1476-4598-13-126↗
- Eri Banno · 1 shared paper, 2017 · strength 0.06
- Ken Kamata · 1 shared paper, 2017 · strength 0.06
- Akira Fukutomi · 1 shared paper, 2015 · strength 0.04
- Shinichi Ohkawa · 1 shared paper, 2015 · strength 0.04
- Nobumasa Mizuno · 1 shared paper, 2015 · strength 0.04
- Masayuki Furukawa · 1 shared paper, 2015 · strength 0.04
- Narikazu Boku · 1 shared paper, 2015 · strength 0.04
- Hiroshi Ishii · 1 shared paper, 2015 · strength 0.04
- Masafumi Ikeda · 1 shared paper, 2015 · strength 0.04
- Hiroki Yamaue · 1 shared paper, 2015 · strength 0.04
- Hideki Ueno · 1 shared paper, 2015 · strength 0.04
- Motoki Miyazawa · 1 shared paper, 2015 · strength 0.04
- Yasuo Ohashi · 1 shared paper, 2015 · strength 0.04
- Masaji Tani · 1 shared paper, 2015 · strength 0.04
- Takuji Okusaka · 1 shared paper, 2015 · strength 0.04
- Kenji Yamao · 1 shared paper, 2015 · strength 0.04
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.